Printer Friendly

Browse Multiple sclerosis topic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
CHARITY MS group's river walk. Oct 11, 2019 138
Predictors of Work Disability ID'd in Multiple Sclerosis Patients; Physical disability, depression, reduced information processing tied to vocational status, work disability. Oct 10, 2019 229
CBD Inflammation Reduction Could Help Alzheimer's Disease. Oct 10, 2019 879
Medical Marijuana Market 2019 Size, Share, Key Trends, Demand, Top Companies Manufacturers, Sales, Revenue and Regional Forecast To 2023. Oct 10, 2019 997
6p-a-day drug could change the lives of MS sufferers; NEW BID TO TACKLE WASTING DISEASE Cholestrol pill could prove a breakthrough. VIVIENNE AITKEN Health Editor Oct 10, 2019 334
WHAT'S ON. Oct 9, 2019 732
Help change lives with big MS appeal; LETTERS. Oct 9, 2019 203
PS100million appeal to beat multiple sclerosis by 2025; Cash raised could provide major medical breakthrough. VIVIENNE AITKEN Oct 9, 2019 360
More cancer drugs confirmed - even more on horizon. Oct 7, 2019 310
Glasgow university to study benefits of mindfulness to ease mood disorders. Oct 6, 2019 506
Paralympics on horizon; MS diagnosis led Colin to his brave new world INSPIRATION AWARD COLIN WALLACE. CALLUM LAW Oct 5, 2019 572
Couple fined over dog poo bags in park. Oct 4, 2019 323
Snowdon wheelchair challenge. Oct 4, 2019 134
MP praises new group to help people with multiple sclerosis. Oct 2, 2019 363
Improved support given to residents with MS. IAN BUNTING Oct 2, 2019 465
Improved care and support for residents with MS. IAN BUNTING Oct 2, 2019 486
Stifel remains buyer of Principia Biopharma into Q4 data readouts. Oct 2, 2019 110
Multiple Sclerosis Market Size Growth Forecasts to 2027 - Sanofi, Teva Pharmaceutical, Bayer, Pfizer, Synthetic Biologic. Oct 1, 2019 495
United States : Nfi Reinforces Commitment To Social Responsibility, Sponsors National Multiple Sclerosis SocietyS Bike Ms: City To Shore. Sep 30, 2019 309
Professional Athletes Swear By CBD's Painkilling Properties. Johnny Vatican Sep 30, 2019 377
They said he had anxiety, but I always thought there was something else. KATIE DICKINSON Reporter katie.dickinson@ncjmedia.co.uk Sep 30, 2019 656
How I cope with..relapsing remitting multiple sclerosis; Your health. Sep 29, 2019 182
Man whose MS was diagnosed as anxiety becomes first to have stem cell treatment for it in Newcastle; Lewis Mawson spent three years under the care of mental health services when doctors diagnosed his MS symptoms as anxiety. Katie Dickinson Sep 29, 2019 699
CHMP Issues Positive Opinion for Rebif Label Amendment During Pregnancy as Clinically Needed and While Breastfeeding. Sep 27, 2019 727
Selma Blair shows off 'peach fuzz' developed from MS treatments. ANI Sep 27, 2019 296
WHAT'S ON. Sep 25, 2019 638
Multiple Sclerosis Therapeutics Market 2019 Global Trend, Segmentation and Opportunities, Forecast 2025. Sep 23, 2019 628
How Margaret's physio enterprise ended up full of energy and wellbeing; Each week, we ask small businesses key questions. Here we speak to Margaret Gear, owner of Yasp Physiotherapy Clinic in Scalloway, Shetland. Sep 23, 2019 621
'JK Rowling spotted my MS and I wish I had acted on it'. Sep 22, 2019 400
'To me, then, it just felt as though he was withdrawing from me' Losing his father as a child had a big impact on Laurence Llewelyn-Bowen. He tells Gabrielle Fagan how he's determined those lessons won't have been learnt in vain... Sep 21, 2019 1493
I'VE AN 18-MONTH WAIT TO FIND OUT IF I'VE GOT M.S. Woman on hospital's 'urgent list'. Sep 19, 2019 395
Merck (NYSE: MRK). Sep 19, 2019 2002
Genentech Presents New Six-year Ocrevus (Ocrelizumab) Data Which Showed That Earlier Initiation and Continuation of Treatment Reduced Disability Progression in Multiple Sclerosis. Sep 18, 2019 241
Anokion Presents New Data Describing Transformative Therapeutic Approach for Treatment of Multiple Sclerosis at ECTRIMS Congress. Sep 18, 2019 368
Happify Health partners with Sanofi to bring prescription digital mental health therapeutics to MS patients. Sep 17, 2019 266
Happify Health partners with Sanofi to bring prescription digital mental health therapeutics to MS patients. Sep 17, 2019 262
Japan : Chugai Presents Results from Second Positive Global Phase III Clinical Study of Satralizumab in NMOSD at ECTRIMS 2019. Clinical report Sep 17, 2019 543
Genentech (SIX: RO, ROG; OTCQX: RHHBY) - Genentech Presents New Six-Year Ocrevus (Ocrelizumab) Data Which Showed That Earlier Initiation and Continuation of Treatment Reduced Disability Progression in Multiple Sclerosis -- 12/9/2019. Sep 17, 2019 789
Cimarron Healthcare Capital Completes Acquisition of Infusion Management. Sep 16, 2019 185
Cimarron Healthcare Capital Completes Acquisition of Infusion Management. Sep 16, 2019 191
United States : Genentech Presents New Six-Year Ocrevus (Ocrelizumab) Data Which Showed That Earlier Initiation and Continuation of Treatment Reduced Disability Progression in Multiple Sclerosis. Sep 16, 2019 306
United States : Genentech Presents New Ocrevus (Ocrelizumab) Biomarker Data That Increase Understanding of Disease Progression in Multiple Sclerosis at ECTRIMS. Sep 16, 2019 226
United States : FTC Sends Warning Letters to Companies Advertising Their CBD-Infused Products as Treatments for Serious Diseases, Including Cancer, Alzheimers, and Multiple Sclerosis. Sep 16, 2019 381
Switzerland : Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis. Sep 16, 2019 303
Switzerland : Roche presents new OCREVUS (ocrelizumab) biomarker data that increase understanding of disease progression in multiple sclerosis at ECTRIMS. Sep 16, 2019 222
Tablet App Seems Reliable, Fast for Cognitive Assessment in MS; Excellent agreement seen between iCAMS tablet application and paper version of the cognitive assessment. Sep 16, 2019 225
Genmab presents detailed results from the phase III ASCLEPIOS I & II studies of ofatumumab in patients with relapsing MS. Clinical report Sep 16, 2019 197
Novartis achieves primary endpoints ofatumumab trials. Sep 16, 2019 181
Genmab presents detailed results from the phase III ASCLEPIOS I & II studies of ofatumumab in patients with relapsing MS. Clinical report Sep 16, 2019 198
Novartis achieves primary endpoints ofatumumab trials. Sep 16, 2019 177
Disarm Therapeutics Presents Data at ECTRIMS 2019 Supporting SARM1 as a Novel Therapeutic Target for Multiple Sclerosis. Sep 16, 2019 338
Neuralgia Treatment Market by Types, Applications, Countries, Companies and Forecasts to 2028 covere. Sep 14, 2019 1039
Patient with MS waited 18 months for wheelchair. Sep 14, 2019 593
Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis. Sep 13, 2019 482
Roche's Ocrevus Multiple Sclerosis Drug Shows Continuous Use Benefit. Sep 13, 2019 203
Atara Biotherapeutics presents results from ATA188 Phase 1 study. Sep 13, 2019 233
Mallinckrodt announces retrospective analysis of Acthar Gel cost per response. Sep 13, 2019 343
Genmab announces Phase III ASCLEPIOS I & II studies met primary endpoints. Sep 13, 2019 224
Roth Capital likes initiatial ATA188 data from Atara Biotherapeutics. Sep 13, 2019 112
Neuralgia Treatment Market by Types, Applications, Countries, Companies and Forecasts to 2028 covere. Sep 13, 2019 1054
Harry Potter author's PS15.3m for MS research; HEALTH. Sep 12, 2019 255
JK Rowling donates [euro]16m to find MS cure. Sep 12, 2019 237
JK Rowling donates PS15m to find MS cure. Sep 12, 2019 236
Merck commences two global Phase III trials of Evobrutinib. Sep 12, 2019 230
Merck commences two global Phase III trials of Evobrutinib. Sep 12, 2019 226
JK Rowling donates [pounds sterling]15m toward research to cure MS after it killed her mother; Anne Rowling died from MS at the age of 45 when JK Rowling was a teenager and the Harry Potter author has donated to a new specialist MS centre at Edinburgh University. Sep 12, 2019 584
Johnson & Johnson's Ponesimod Shows Potential For Sclerosis Treatment. Sep 12, 2019 177
TG Therapeutics presents ublituximab data at ECTRIMS Congress. Sep 12, 2019 393
Rowling's PS15.3m boost for MS centre. Sep 12, 2019 102
Celgene Corporation (NASDAQ: CELG) - Data from Ozanimod Clinical Development Program in Relapsing Forms of Multiple Sclerosis to Be Presented at the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis -- 9/9/2019. Sep 12, 2019 822
The Daily Biotech Pulse: Lexicon Snaps Sanofi Diabetes Partnership With $260M Settlement, Celyad Offering, Multiple Sclerosis Conference Gets Underway. Conference news Sep 11, 2019 616
Serum Biomarker Linked to Brain Atrophy in Multiple Sclerosis; Changes in serum neurofilament light chain levels tied to disability status and brain fraction atrophy. Clinical report Sep 11, 2019 249
Roche presents new OCREVUS (ocrelizumab) biomarker data that increase understanding of disease progression in multiple sclerosis at ECTRIMS. Sep 10, 2019 341
MS sufferer aiming for treatment in Russia; ? Woman denied by UK service. Sep 10, 2019 501
The Daily Biotech Pulse: Translate Bio Halts mRNA Therapy Trial, Roche Multiple Sclerosis Biomarker Data, D-Day For Xeris. Sep 10, 2019 1011
Genentech: blood NfL levels 'significantly lowered' following Ocrevus treatment. Sep 10, 2019 377
Tiziana Life Sciences reports Foralumab was tolerated at all doses. Clinical report Sep 10, 2019 254
Merck (NYSE: MRK). Sep 10, 2019 1870
Fundraiser run by MS sufferer back next month; CHARITY. Sep 9, 2019 242
Take Cake Break with help of Hairy Bikers. Sep 7, 2019 441
Germany : Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine. Sep 7, 2019 383
8 Places Of Residential Care Service For People With Dependency And Disability, With Multiple Sclerosis And Related, In A Housing Specialized In Ganao, Within The Riojan System For Personal Autonomy. Sep 7, 2019 139
NervGen Pharma Announces Clinical Development Plan for the Treatment of Nerve Damage and Neurodegenerative Diseases. Sep 6, 2019 1111
Global Autoimmune Disease Diagnostic Market to 2025 by Disease, Tests Type, Regions. Sep 6, 2019 726
Managing director set fire to himself in van parked in lay-by in Congleton, inquest hears; The body of Robin Lonsdale was discovered by a member of the public. Sep 6, 2019 1270
Managing director set fire to himself in van parked in lay-by in Congleton, inquest hears; The body of Robin Lonsdale was discovered by a member of the public. Sep 6, 2019 1270
8 Places Residential Care Service People Dependence And Disability, Multiple Sclerosis In Specialized Housing Within System For Autonomy And Dependence. Sep 5, 2019 145
Alexion Pharmaceuticals (NASDAQ: ALXN) - Alexion Announces Upcoming Data Presentations At 35th Congress Of The European Committee For Treatment And Research In Multiple Sclerosis -- 28/8/2019. Sep 5, 2019 415
WHAT'S ON. Sep 4, 2019 632
Sandoz announces global commercialisation deal for multiple sclerosis biosimilar natalizumab. Sep 4, 2019 157
Overactive Bladder Treatment Market Report 2019, Size, Share, Historical Analysis, Emerging Trends, OAB Treatment Industry Segments, Growth Factors, Development Status And Regional Forecast to 2023. Report Sep 4, 2019 864
Sandoz announces global commercialisation deal for multiple sclerosis biosimilar natalizumab. Sep 4, 2019 153
Delivery Of Medicinal Products For The Treatment Of Multiple Sclerosis With The Active Substance Teriflunomid And Alemtuzumab. Sep 4, 2019 144
Polpharma Biologics signs global commercialisation agreement for biosimilar Natalizumab for MS. Sep 3, 2019 186
Polpharma Biologics signs global commercialisation agreement for biosimilar Natalizumab for MS. Sep 3, 2019 182
Merck (NYSE: MRK). Sep 3, 2019 1870
Novartis Teams Up With Polpharma To Develop Multiple Sclerosis Drug. Sep 3, 2019 185
Novartis' ofatumumab indicates superiority over Aubagio in two phase three trials. Sep 2, 2019 174
Novartis' ofatumumab indicates superiority over Aubagio in two phase three trials. Sep 2, 2019 170
Novartis Reports Positive Results From Two Multiple Sclerosis Trials. Aug 30, 2019 195
Novartis announces Phase III MS studies of ofatumumab met primary endpoints. Aug 30, 2019 358
last chance to have a first dance; GROOM'S FUNDRAISING PLEA FOR CLINICAL TRIALS Futuristic robot exo-skeleton giving MS sufferer Richard hope for wedding day Our last chance to have first dance. Aug 30, 2019 492
MS sufferer Leon's stem cell appeal. Aug 30, 2019 198
Invacare to pay dividend of USD0.0125 per share. Aug 30, 2019 143
Specialty Generics Market is Estimated to Value $174.9 Billion By 2025: Grand View Research, Inc. Aug 30, 2019 833
The Daily Biotech Pulse: Genmab-Novartis Multiple Sclerosis Drug Aces Late-Stage Studies, Akari Nets Orphan Drug Designation. Aug 30, 2019 587
Los costos de los medicamentos para la EM se multiplican por siete en 10 anos para los pacientes de Medicare. Norton, Amy Perspectiva general del medicame Aug 29, 2019 1088
Alexion Pharmaceuticals (NASDAQ: ALXN) - Alexion Announces Upcoming Data Presentations At 35th Congress Of The European Committee For Treatment And Research In Multiple Sclerosis -- 28/8/2019. Aug 29, 2019 415
Merck (NYSE: MRK). Aug 28, 2019 1884
Cake fundraiser for MS gets biker boost. Aug 28, 2019 236
Regular Vaccines Advised With Multiple Sclerosis. Report Aug 28, 2019 368
For Medicare Patients, Costs of MS Drugs Rise Sevenfold Over 10 Years. Norton, Amy Aug 28, 2019 783
Long-Term Night-Shift Work May Up Risk for Multiple Sclerosis; Overall, no link found between rotating night-shift work history and MS risk in two large nurse cohorts. Aug 28, 2019 267
Guidelines Updated for Vaccination in Multiple Sclerosis; MS patients advised to follow all local vaccine standards except in case of specific contraindications. Aug 28, 2019 272
WHAT'S ON. Aug 28, 2019 588
Prices Spike for Drugs Used to Treat Multiple Sclerosis; 2006-2016 Medicare claims show 10.2-fold, 7.2-fold hikes in pharmaceutical, out-of-pocket spending. Aug 27, 2019 287
Super way to raise money and awareness for health charity. Aug 27, 2019 119
FACT.MR Magnetic Therapy Devices Market 2018 to 2028. Aug 27, 2019 1264
Emerging Opportunities in Magnetic Therapy Devices Market with Current Trends Analysis. Aug 26, 2019 1279
Magnetic Therapy Devices Market Value Share 2018 to 2028. Aug 26, 2019 1264
AllianceRx Walgreens Prime adds LDDs. Aug 26, 2019 183
Provision Of Fingolimod 2019. Aug 22, 2019 204
New chair for the MRC Neurosciences and Mental Health Board. Aug 22, 2019 406
Tonix Pharmaceuticals, MGH enter research collaboration for TNX-1500. Aug 21, 2019 195
Merck (NYSE: MRK). Aug 21, 2019 1882
Summit to be proud of; MS sufferer reaches top of peak despite condition. Aug 20, 2019 281
New chair for the MRC Neurosciences and Mental Health Board. Aug 20, 2019 402
Ex-Cavs coach Blatt reveals multiple sclerosis battle. Aug 20, 2019 353
Global Neurologic Disorders Therapeutics Market by Application & Geography - Forecast to 2023. Aug 19, 2019 698
Monovaccine (Epstein-Barr Virus) Market Potential is estimated to be US$ 2.0 Billion / Opportunities and Forthcoming Developments. Aug 19, 2019 853
MP MAKES CANNABIS LAW VOW; Pledge over medicinal use of drug. Aug 17, 2019 287
Impact of Existing and Emerging Neuralgia Treatment Market Trends and Forecast 2018-2028. Aug 15, 2019 1160
Boost for MS as ageing process in rat cells reversed. Aug 15, 2019 129
New hope to slow ageing of brains; UK & WORLD. Aug 15, 2019 131
New hope to slow ageing of brains; UK & WORLD. Aug 15, 2019 131
Research report covers the Neuralgia Treatment Market share and Growth, 2018-2028. Aug 14, 2019 1160
New MS group holds fun day. Aug 14, 2019 113
Merck (NYSE: MRK). Aug 14, 2019 1882
United States : Smoldering spots in the brain may signal severe MS. Aug 13, 2019 916
Scans Reveal 'Smoldering' Spots in Brains Touched by MS. Aug 13, 2019 452
Framework Agreement For The Supply Of Medicines For The National Multiple Sclerosis Program (romania-bucharest: Pharmaceutical Products). Aug 9, 2019 207
Atara Biotherapeutics reports Q2 EPS ($1.60), consensus ($1.50). Financial report Aug 8, 2019 145
Spa helps Selma Blair recover from MS treatments. Aug 8, 2019 148
Biogen Idec (NASDAQ: BIIB) - Diroximel Fumarate Demonstrated Significantly Improved Gastrointestinal Tolerability Profile Compared to Dimethyl Fumarate in Patients with Multiple Sclerosis -- 30/7/2019. Clinical report Aug 8, 2019 728
Vaccination Does Not Up Risk for Developing Multiple Sclerosis; Odds of MS lower in participants with vaccination, especially for influenza, tick-borne illness. Aug 6, 2019 297
Merck (NYSE: MRK). Aug 6, 2019 1871
Help find muggers who attacked my husband. Aug 6, 2019 601
Devoted carer for his wheelchair-bound wife beaten to a pulp by muggers; The Southport man suffered fractured cheekbone, eye socket and nose in violent street robbery. Aug 5, 2019 717
New initiative to provide medicines to needy patients. Aug 3, 2019 283
Global Multiple Sclerosis Therapeutics Market Outlook to 2025 - Key Players are Biogen, Teva Pharmaceuticals, Bayer, Sanofi Genzyme, Novartis, and Pfizer. Aug 2, 2019 508
Market Forecast Report on Magnetic Therapy Devices Market 2018-2028. Aug 2, 2019 1265
Magnetic Therapy Devices Market Shares, Strategies and Forecast Worldwide, 2018 to 2028. Aug 2, 2019 1265
Selma Blair struggles with insomnia amid MS battle. Aug 1, 2019 494
Progentec Diagnostics, Karate Health Merge to Broaden Comprehensive Autoimmune Disease Management Platforms. Aug 1, 2019 231
Progentec Diagnostics, Karate Health Merge to Broaden Comprehensive Autoimmune Disease Management Platforms. Aug 1, 2019 232
Deal snapshot: PROGENTEC DIAGNOSTICS, KARATE HEALTH MERGE. Aug 1, 2019 101
Unmasking the Masquerader: A Delayed Diagnosis of MS and Its 4.5 Years of Implications in an Older African American Male. Dong, Deanna; Carlson, Joshua; Ruberwa, Joseph; Snihur, Thomas; Obaidi, Nawar Al-; Bustillo, Jose Aug 1, 2019 3192
Prevalence of Anti-JC Virus (JCV) Antibodies in the Multiple Sclerosis (MS) Population in Cyprus: A Retrospective Study. Lambrianides, Sakis; Demetriou, Christiana A.; Tillyris, Andis; Kkolou, Elena; Gaglia, Eftychia; Agk Clinical report Aug 1, 2019 2954
Rapid and Efficient Purification of Functional Collectin-12 and Its Opsonic Activity against Fungal Pathogens. Zhang, Jie; Li, Anna; Yang, Chang-Qing; Garred, Peter; Ma, Ying Jie Aug 1, 2019 4953
Bilateral Anterior and Intermediate Uveitis with Occlusive Vasculitis as Sole Manifestation of Relapse in Multiple Sclerosis. Pedraza-Concha, Angelica; Brandauer, Karin; Tello, Alejandro; Rangel, Carlos Mario; Scheib, Christia Aug 1, 2019 2264
Rituximab as Rescue Therapy for Aggressive Pediatric Multiple Sclerosis. Vartzelis, George; Maritsi, Despoina; Nikolaidou, Maria; Garoufi, Anastasia; Kilidireas, Constantino Aug 1, 2019 1670
Pain Study. Bebermeyer, Carrie Aug 1, 2019 344
Stem cell therapy for neurological disorders. Alessandrini, M.; Preynat-Seauve, O.; Bruin, K. de; Pepper, M.S. Aug 1, 2019 8107
United States : Runners World features Hanger Clinic orthotic patient and marathon runner Cheryl Hile. Jul 31, 2019 135
Biogen Idee (NASDAQ: BIIB) - Diroximel Fumarate Demonstrated Significantly Improved Gastrointestinal Tolerability Profile Compared to Dimethyl Fumarate in Patients with Multiple Sclerosis - 30/7/2019. Clinical report Jul 31, 2019 728
Alkermes and Biogen announce results from EVOLVE-MS-2 Phase 3 study. Clinical report Jul 30, 2019 117
Alkermes, Biogen announce results of EVOLVE-MS-2 Phase 3 study. Clinical report Jul 30, 2019 345
Merck (NYSE: MRK). Jul 30, 2019 1883
MRI scans may predict the future for MS patients. Jul 29, 2019 488
Friends raise PS10k to help people battling with MS; Charity: Women raising funds for Revive in honour of much-loved Lucy. Jul 29, 2019 353
Selma Blair flaunts shaved head after being discharged from multiple sclerosis treatment. Jul 26, 2019 333
Surgery Not a Relapse Risk for MS Patients. Jul 26, 2019 353
Banner Life Sciences Enrolls First Subject in Randomised, Double-Blind Head-to-Head Study of Bafiertam and Tecfidera for Comparative Assessment of GI Tolerability. Jul 24, 2019 379
Life science leader renews lease at midtown Himmel + Meringoff tower. Jul 24, 2019 198
Merck (NYSE: MRK). Jul 24, 2019 1882
Chinese medical watchdog approves Novartis' Gilenya. Jul 23, 2019 147
Chinese medical watchdog approves Novartis' Gilenya. Jul 23, 2019 143
Biogen raises FY19 EPS view to $31.50-$32.30 from $28.00-$29.00. Jul 23, 2019 138
Artistic actress auctions self-portrait for MS charity. Jul 21, 2019 333
Migrants and multiple sclerosis; DR MIRIAM STOPPARD; Helping to keep you fit and healthy. Jul 19, 2019 111
Migrants and multiple sclerosis; DR MIRIAM STOPPARD; Helping to keep you fit and healthy; HEALTH NEWS. Jul 19, 2019 111
Migrants and multiple sclerosis; HEALTH NEWS. Jul 19, 2019 112
Novartis Says Multiple Sclerosis Product Approved In China. Jul 19, 2019 158
Supply Of A Medicinal Product (drug) Dimethyl Fumarate 240 Mg Used In A Health/Drug Program For The Treatment Of Multiple Sclerosis (ms) - Type - Continuation Of Treatment For The Needs Of The Multinational City Hospital Jzef Strusia In Poznan. Jul 19, 2019 242
FRAX Score Underestimates Risk for Fracture in Multiple Sclerosis; Multiple sclerosis is a risk factor for major osteoporotic fracture independent of FRAX score. Jul 19, 2019 291
WHAT'S ON. Jul 17, 2019 627
A host of live acts at Pissouri festival. Jul 17, 2019 321
Gut Bacteria Can Protect Nervous System And Brain From Harmful Viruses. Jul 17, 2019 515
Supply Of Drugs Used In Drug Programs For The Treatment Of Multiple Sclerosis (poland-poznan: Pharmaceutical Products). Jul 16, 2019 285
Merck (NYSE: MRK). Jul 16, 2019 1880
MS Relapse Risk Not Increased in Postoperative Period; Odds of postoperative versus preoperative relapse were not increased in unadjusted, adjusted analyses. Jul 16, 2019 209
Obesity May Boost Odds for MS in Kids. Jul 16, 2019 588
Obesity Linked to Increased Risk for Pediatric Multiple Sclerosis; Obese patients have significantly more relapses on first-line treatment with IFN beta, glatiramer acetate. Clinical report Jul 15, 2019 235
Third Clinical Site for Phase 2 Progressive MS Trial. Jul 15, 2019 171
New hope for therapy that treats multiple sclerosis. Jul 15, 2019 768
We feared for six months that our mum was dying, but her 'cancer' was a bladder stone; HARROWING DISPUTE WITH HEALTH CHIEFS Family fought for months to get second opinion for Isla as she battled MS and dementia. Jul 15, 2019 630
Cyxone's first-in-human MS study of T20K to be concluded in the second half of 2019. Jul 15, 2019 270
Cyxone's first-in-human MS study of T20K to be concluded in the second half of 2019. Jul 15, 2019 266
Dad Channels his energy into 21 mile swim for MS fund; MARKING 21 YEARS SINCE HE WAS DIAGNOSED WITH THE CONDITION. Jul 12, 2019 676
Standing Frame Program Can Up Motor Function in Progressive MS; Motor function increased significantly but not to degree considered a priori as clinically meaningful. Jul 12, 2019 241
MediciNova announces Phase 3 clinical trial plan for MN-166. Jul 11, 2019 384
Increased Cancer Risk Seen in Multiple Sclerosis Patients; Cancer risk up for MS patients versus non-MS controls, especially in respiratory, urinary, CNS organs. Jul 9, 2019 272
Cannabinoid Therapy Market Sales Set to Rise with Concentrated Investment by Market Players, details. Jul 8, 2019 896
Cannabinoid Therapy Market Sales Set to Rise with Concentrated Investment by Market Players, details. Jul 7, 2019 882
MS BREAKTHROUGH; Breath test could lead to much quicker diagnosis. Jul 5, 2019 188
Peru : Adults between 20 and 40 years are prone to have Multiple Sclerosis. Jul 5, 2019 419
Disabled man is driven to despair by parking ticket. Jul 4, 2019 642
Bank supports major healthcare projects in Bahrain. Jul 4, 2019 249
Merck (NYSE: MRK). Jul 2, 2019 1883
Mast Cell Activation Syndrome: A Key Exploration in Recovering from Chronic Lyme Disease. Patel, Raj; Farshchian, Thalia; Forsgren, Scott Jul 1, 2019 5150
Pelvic Mass Leading to an Elevated Post-Void Residual in a Patient With Multiple Sclerosis. Singh, Marybeth Jul 1, 2019 1404
MS Linked to Higher Cancer Risk. Jul 1, 2019 625
Multiple Sclerosis for the Non-Neurologist (online access included). Book review Jul 1, 2019 108
MS linked to higher rates of hoarding behavior. Dotinga, Randy Jul 1, 2019 612
Atara Biotherapeutics presents initial ATA188 Phase 1 safety results. Jun 29, 2019 200
United States : OhioHealth Medical Minute: OhioHealth First To Give New FDA Approved Multiple Sclerosis Medication. Jun 29, 2019 473
MS support group open to affected. Jun 26, 2019 177
Funding call for multiple sclerosis; E&S BRIEFING. Jun 25, 2019 173
Immunic to present unpublished IMU-838 data at GIIDS. Jun 24, 2019 333
The Impact of Cognitive Functioning on Daily Occupations for People with Multiple Sclerosis: A Qualitative Study. Mc Auliffe, Aoife; Hynes, Sinead M. Report Jun 22, 2019 6806
Spellar in call to boost MS funding; E&S BRIEFING. Jun 21, 2019 171
Ms-adaptation Courses 2020-2022, Services In Swedish. Jun 20, 2019 205
Doctors hopeful MS cure around corner. Jun 19, 2019 1017
WHAT'S ON. Jun 19, 2019 604
It's so bad he wanted them to amputate his legs... how can someone be left in such a state in this day and age; EXCLUSIVE MUM BEGS FOR HELP FOR SICK SON. Jun 17, 2019 804
Medication deal could lead to NICE approval; DR MIRIAM STOPPARD; Helping to keep you fit and healthy; GOOD NEWS. Jun 17, 2019 104
Dad, 37, trapped forever in foetal position begs doctors to amputate his leg; WARNING - GRAPHIC IMAGE: Thomas McKell, from Glasgow, Scotland, has been fighting MRSA for four years and now has a gaping wound behind his knee that's untreatable. Jun 17, 2019 821
Second Clinical Site To Enroll Patients In BrainStorm MS Phase 2 Study. Jun 17, 2019 259
Golden girl Goodall's stunning comeback. Jun 13, 2019 438
First international scientific conference on Multiple Sclerosis kicks off in Damascus. Conference news Jun 13, 2019 151
More than 700 multiple sclerosis patients receiving care at HMC. Jun 13, 2019 477
HMC treats 700 patients with multiple sclerosis. Jun 12, 2019 469
'I was left with just PS30 to live on' More than two decades on from her Multiple Sclerosis diagnosis, Wendy Fitton is locked in a battle with the DWP after a change in the rules led to a dramatic cut in the benefits she received. Jun 9, 2019 1882
Selma Blair replaces cane with walking bike as she battles multiple sclerosis. Jun 8, 2019 449
Postal problem leaves MS patient short of medicine; Royal Mail: Couple's home on tight bend 'too dangerous' to get deliveries. Jun 7, 2019 402
Celgene says FDA, EMA, accept applications for ozanimod. Jun 6, 2019 136
Invitation to walk, run or stroll to aid charity; E&S BRIEFING. Jun 5, 2019 150
Supply Of Medicinal Products For Patients Treated As Part Of The Multiple Sclerosis Drug (ms) Program (poland-warsaw: Various Medicinal Products). Jun 3, 2019 126
Walk, roll or stroll for MS event. Jun 1, 2019 179
Dermatologic research on cannabinoids well underway. Baumann, Leslie S. Jun 1, 2019 2276
The Adverse Effects of High-dose Corticosteroids with Early and Late Severe Morbidity in the Treatment of Patients with Multiple Sclerosis: Long-term Observation Results/Multipl Skleroz Hastalarinin Atak Tedavisinde Yuksek Doz Kortikosteroid Kullaniminin Erken ve Gec Donem Agir Morbiditeye Yol Acan Yan Etkileri: Uzun Donem Gozlem Sonuclari. Omerhoca, Sami; Akkag, Sinem Yazici; Hasimoglu, Zerrin Yildirim; Erdogan, Sebatiye; Kale, Nilufer Jun 1, 2019 3118
Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis/Relapsing-remitting Multipl Skleroz Hastalarinda Subkutan Ofatumumab. Onder, Halil Report Jun 1, 2019 1070
The comparisons of blood plasma and cerebrospinal fluid S100B protein concentrations in patients with Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosis. Tarasiuk, J.; Kapica-Topczewska, K.; Chorazy, M.; Borowik-Zareba, A.; Mroczko, B.; Kochanowicz, J.; Jun 1, 2019 2850
The physical and occupational activity of patients with multiple sclerosis depending on the form of clinical disease. Wyszynska, E; Sienkiewicz, D; Kulak, W Jun 1, 2019 3377
Tamsulosin-induced Hyperprolactinemia in a Patient with Multiple Sclerosis: A Case Report/Multipl Sklerozlu Bir Hastada Tamsulosine Bagli Hiperprolaktinemi: Olgu Sunumu. Gorgel, Ahmet; Soylu, Ahmet; Gorgel, Sacit; Tecellioglu, Mehmet; Sarier, Mehmet Jun 1, 2019 1744
Monthly Pulse Methylprednisolone Therapy is Effective in Preventing Permanent Disease Progression in Secondary Progressive Multiple Sclerosis. Ozakbas, Serkan; Cinar, Bilge Piri; Oz, Didem; Kosehasanogullari, Gorkem; Kursun, Behice Bircan; Kah Clinical report Jun 1, 2019 3280
Care Collaboration For Vets With MS. Jun 1, 2019 951
FDA Approves New MS Drugs. Jun 1, 2019 174
Exploring life history methodology in chronic illness: a study in Relapsing Remitting Multiple Sclerosis. Burke, Therese; Patching, Joanna Report Jun 1, 2019 4417
Help and support for MS sufferers. May 31, 2019 254
Biogen announces new interim data from EVOLVE-MS-1 study. May 30, 2019 410
Iman Ali talks about living with multiple sclerosis on World MS Day. May 30, 2019 230
WHAT'S ON. May 29, 2019 727
Supporters Building on Success; ADVERTISEMENT. May 29, 2019 524
Lighting up lives to back charity. May 29, 2019 200
Supply Of Electric Chairs For The Multiple Sclerosis Day Hospital Of The University Hospital Ntra. Mrs. De Candelaria, Through Simplified Open Adjudication Procedure And Ordinary Processing, Co-financed By The European Regional Development Fund (f.e.d.e.r. May 25, 2019 155
DIY SOS family describes what happened after filming and it's not all good news; Lin and Stuart Philp say they are extremely grateful for the help they got and have nothing but praise for the amazing volunteers who helped rebuild their home - but they have been left with problems. May 25, 2019 1241
DIY SOS family open up about what happened when the cameras stopped rolling; The team transformed the family home - but it wasn't all good news. May 25, 2019 505
Celgene and the Multiple Sclerosis Association of America Team Up to Launch MS MindShift for Awareness of Multiple Sclerosis and Brain Health. May 24, 2019 413
WHAT'S ON. May 22, 2019 706
Living Full Out Radio Show: Embracing Change and Making Adjustments. May 22, 2019 453
Auto-Injectors Market Highlights Key Development Factors and Upcoming Trends During forecast 2016-20. May 22, 2019 1001
Auto-Injectors Market Highlights Key Development Factors and Upcoming Trends During forecast 2016-20. May 22, 2019 984
Greene King pub 'turns wheelchair user away telling her "we don't do disableds"'; Comedian Andy Smart was visiting the Greene King pub with his sister Ros, who has multiple sclerosis and uses a wheelchair. May 22, 2019 664
Celgene Corporation (NASDAQ: CELG) - Celgene and the Multiple Sclerosis Association of America Team Up to Launch MS MindShift for Awareness of Multiple Sclerosis and Brain Health -- 21/5/2019. May 22, 2019 591
Investigating the antimicrobial efficacy of mesenchymal stromal cells as a novel potential therapy for Mycobacterium avium pulmonary infection. May 21, 2019 463
Pigment-Producing Stem Cells Can Regenerate Vital Part Of Nervous System. May 20, 2019 654
United States : Analysis Showed Oral Ozanimod Reduced Brain Volume Loss Across All Age Subgroups in Adults with Relapsing Multiple Sclerosis. May 20, 2019 515
Phytotherapy as a Complementary Medicine for Multiple Sclerosis/Multipl Sklerozda Tamamlayici Tedavi Olarak Fitoterapi. Rabiei, Zahra Report May 18, 2019 4263
Living Full Out Radio Show: Embracing Change and Making Adjustments. May 17, 2019 462
Supply Of Dimethyl Fumarate (doe) Indicated For The Treatment Of Recurrent Remitting Multiple Sclerosis (spain-vitoria-gasteiz: Pharmaceutical Products). May 17, 2019 140
19/43 Drugs For The Treatment Of Multiple Sclerosis. May 17, 2019 150
Enzo Biochem Issued United States Patent for Treatment of Liver Cancer Using Ozanimod. Disease/Disorder overview May 16, 2019 291
Health and fitness Submit your events at dailyherald.com/share. Calendar May 16, 2019 755
Merck (NYSE: MRK). May 15, 2019 1882
Genentech (SIX: RO, ROG; OTCQX: RHHBY) - Genentech to Present New OCREVUS (ocrelizumab) Data Analyses Showing Significant Reduction of Disability Progression in Relapsing and Primary Progressive Multiple Sclerosis at the AAN Annual Meeting -- 7/5/2019. May 14, 2019 667
icometrix secures new funding of USD18m. May 14, 2019 138
icometrix secures new funding of USD18m. May 14, 2019 134
Fundraisers' daily hill climb is Jurassic lark. May 13, 2019 504
OAPs' taste for hash brownies. May 11, 2019 112
Merck KGaA says 48-week evobrutinib data continue lesions reduction. Clinical report May 10, 2019 248
Cannabinoid Therapy Market Soaring Demand Assures Motivated Revenue Share during 2018-2027. May 9, 2019 882
Cannabinoid Therapy Market Soaring Demand Assures Motivated Revenue Share during 2018-2027. May 9, 2019 862
Cannabinoid Therapy Market Soaring Demand Assures Motivated Revenue Share during 2018-2027. May 9, 2019 896
Mexico op could be mum's last hope to get back on her feet. May 9, 2019 637
Relapsing MS Patients Who Received Aubagio Experienced a Reduced Risk of Relapse Regardless of Prior Treatment Status in a Post-Hoc Analysis. May 9, 2019 287
Biogen Idee (NASDAQ: BIIB) - Data at AAN Demonstrate Biogen's Leadership and Commitment to Innovation in MS -- 7/5/2019. May 9, 2019 809
Pear Therapeutics starts feasibility study for prescription digital therapeutic. May 7, 2019 181
Pear Therapeutics starts feasibility study for prescription digital therapeutic. May 7, 2019 177
Celgene says analysis shows oral ozanimod reduced brain volume loss. May 7, 2019 248
Merck (NYSE: MRK). May 7, 2019 1882
Canada : Expanded Multiple Sclerosis Drug Coverage For Patients. May 2, 2019 212
United States : Teva to Present New Central Nervous System Portfolio Data at 71st Annual Meeting of the American Academy of Neurology. May 2, 2019 267
Call For Requests To Participate - Provide Catering Services. May 2, 2019 234
WHAT'S ON. May 1, 2019 755
MSP gets behind MS cause. May 1, 2019 143
Novel SNARE Complex Polymorphisms Associated with Multiple Sclerosis: Signs of Synaptopathy in Multiple Sclerosis. Yalin, Osman Ozgur; Edgunlu, Tuba Gokdogan; Celik, Sevim Karakas; Emre, Ufuk; Gunes, Taskin; Erdal, May 1, 2019 4171
Novartis to present 53 abstracts from neurological portfolio, pipeline at AAN. Apr 30, 2019 109
Tractor run a success, but could be the last; FUNDRAISING. Apr 29, 2019 152
Cannabinoid Therapy Market Regional Growth Trends Focusing on Manufacturers Recorded during 2018-202. Apr 29, 2019 882

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters